ZEAL moves to new headquarters

Article

ZEAL Optics has relocated its corporate headquarters to a space in historic downtown Bolder, CO, the company announced

Boulder, CO-ZEAL Optics has relocated its corporate headquarters to a space in historic downtown Bolder, CO, the company announced.

The community in which ZEAL now calls home matches the company’s eco-conscious values. Most of the town bikes to work, hits the rooftop bars for happy hour and will always be seen running, hiking or rock climbing on the weekends.

In the midst of this, ZEAL reports it has created an environment that is vibrant and promotes open thinking and that will affect how the company develops new markets, provides services for retailers, and connects with customers, said John Sanchez, president.

ZEAL has committed itself to reducing its carbon footprint through innovative manufacturing processes. It is the only sunglass brand made from a plant-based resin. In line with its environmentally conscious culture, the renovated offices--a building that has existed in Boulder since 1898 and is the former home to the W.W. Wolf’s Meat Market--uses locally obtained beetle-kill wood materials for construction.

“We are very excited to be Boulder-based as we craft our future lines,” said Joe Prebich, director of marketing. “It is more important than ever to have real, strong roots in what makes us who we are! It's going to be a great ride!”

For more articles in this issue of InDispensable, click here.

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.